Lantern Pharma Inc. (LTRN) Market Performance Overview

Lantern Pharma Inc., a clinical‑stage biopharmaceutical company listed on Nasdaq, experienced a 2.34 % increase in its share price during a 24‑hour period ending at 01:45 PM Central Europe on Wednesday, 21 October 2026. The stock traded at USD 0.66 per share.

Key Market Metrics

  • Shares outstanding: 12.8 million
  • Current market capitalization: USD 8.2 million
  • Volume traded in the last 24 hours: USD 1.2 million
  • Price change since month‑end: –56.27 %
  • Simple moving average (200 days): USD 2.57
  • 52‑week high: USD 4.34 (recorded on 1 July 2026)
  • 52‑week low: USD 0.60 (recorded on 20 October 2026)
  • Iqstel (IQST): up 1.35 %, trading at USD 0.90, market cap USD 9.7 million
  • Petro‑Victory Energy (VRY.V): flat 0 %, trading at CAD 0.37, market cap CAD 13.7 million
  • Upland Software (UPLD): up 0.3 %, trading at USD 3.33, market cap USD 9.8 million
  • Bullfrog Ai (BFRG): down –6.64 %, trading at USD 0.49, market cap USD 9.8 million
  • Ensysce Biosciences (ENSC): down –0.8 %, trading at USD 0.50, market cap USD 9.8 million

Company Profile

Lantern Pharma Inc. is a clinical‑stage biopharmaceutical company headquartered in the United States. The company focuses on integrating artificial intelligence, machine learning, and genomic data to streamline drug development and to identify patients most likely to benefit from targeted oncology therapies. Lantern Pharma is listed on the Nasdaq stock exchange and maintains an online presence through its website at www.lanternpharma.com .